Literature DB >> 25836968

The European Partnership for Alternative Approaches to Animal Testing (EPAA): promoting alternative methods in Europe and beyond.

Gwenole Cozigou1, Jonathan Crozier2, Coenraad Hendriksen3, Irene Manou4, Tzutzuy Ramirez-Hernandez5, Renate Weissenhorn6.   

Abstract

Here in we introduce the European Partnership for Alternative Approaches to Animal Testing (EPAA) and its activities, which are focused on international cooperation toward alternative methods. The EPAA is one of the leading organizations in Europe for the promotion of alternative approaches to animal testing. Its innovative public-private partnership structure enables a consensus-driven dialogue across 7 industry sectors to facilitate interaction between regulators and regulated stakeholders. Through a brief description of EPAA's activities and organizational structure, we first articulate the value of this collaboration; we then focus on 2 key projects driven by EPAA. The first project aims to address research gaps on stem cells for safety testing, whereas the second project strives for an approach toward demonstration of consistency in vaccine batch release testing. We highlight the growing need for harmonization of international acceptance and implementation of alternative approaches and for increased international collaboration to foster progress on nonanimal alternatives.

Mesh:

Year:  2015        PMID: 25836968      PMCID: PMC4382626     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  6 in total

1.  The consistency approach for the quality control of vaccines.

Authors:  Coenraad Hendriksen; Juan L Arciniega; Lukas Bruckner; Michel Chevalier; Emmanuelle Coppens; Johan Descamps; Michel Duchêne; David Michael Dusek; Marlies Halder; Hans Kreeftenberg; Alexandrine Maes; Keith Redhead; Satish D Ravetkar; Jean-Marc Spieser; Hanny Swam
Journal:  Biologicals       Date:  2007-09-24       Impact factor: 1.856

2.  Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.

Authors:  David Basketter; Nathalie Alépée; Silvia Casati; Jonathan Crozier; Dorothea Eigler; Peter Griem; Bruno Hubesch; Joop de Knecht; Robert Landsiedel; Kimmo Louekari; Irene Manou; Gavin Maxwell; Annette Mehling; Tatiana Netzeva; Thomas Petry; Laura H Rossi
Journal:  Regul Toxicol Pharmacol       Date:  2013-10-16       Impact factor: 3.271

3.  Can acute dermal systemic toxicity tests be replaced with oral tests? A comparison of route-specific systemic toxicity and hazard classifications under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS).

Authors:  Nigel P Moore; David J Andrew; Donald L Bjerke; Stuart Creton; David Dreher; Thomas Holmes; Pilar Prieto; Troy Seidle; Tim G Rowan
Journal:  Regul Toxicol Pharmacol       Date:  2013-02-24       Impact factor: 3.271

4.  Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union.

Authors:  Erwin Annys; Richard Billington; Rick Clayton; Klaus-Dieter Bremm; Michael Graziano; Jo McKelvie; Ian Ragan; Michael Schwarz; Jan Willem van der Laan; Charles Wood; Mattias Öberg; Piet Wester; Kevin N Woodward
Journal:  Regul Toxicol Pharmacol       Date:  2014-04-24       Impact factor: 3.271

Review 5.  Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors.

Authors:  K Schroeder; K D Bremm; N Alépée; J G M Bessems; B Blaauboer; S N Boehn; C Burek; S Coecke; L Gombau; N J Hewitt; J Heylings; J Huwyler; M Jaeger; M Jagelavicius; N Jarrett; H Ketelslegers; I Kocina; J Koester; J Kreysa; R Note; A Poth; M Radtke; V Rogiers; J Scheel; T Schulz; H Steinkellner; M Toeroek; M Whelan; P Winkler; W Diembeck
Journal:  Toxicol In Vitro       Date:  2010-12-15       Impact factor: 3.500

6.  PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshop.

Authors:  Jos G Bessems; George Loizou; Kannan Krishnan; Harvey J Clewell; Camilla Bernasconi; Frederic Bois; Sandra Coecke; Eva-Maria Collnot; Walter Diembeck; Lucian Romeo Farcal; Liesbeth Geraets; Ursula Gundert-Remy; Nynke Kramer; Gabriele Küsters; Sofia B Leite; Olavi R Pelkonen; Klaus Schröder; Emanuela Testai; Iwona Wilk-Zasadna; José-Manuel Zaldívar-Comenges
Journal:  Regul Toxicol Pharmacol       Date:  2013-11-26       Impact factor: 3.271

  6 in total
  9 in total

1.  Special issue: global 3Rs efforts - making progress and gaining momentum.

Authors:  Leticia V Medina; Joachim Coenen; Michael D Kastello
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

2.  The 3Rs Principle in Animal Experimentation: A Legal Review of the State of the Art in Europe and the Case in Italy.

Authors:  Enrico Maestri
Journal:  BioTech (Basel)       Date:  2021-05-20

Review 3.  IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

Authors:  Xiaoqing Chang; Yu-Mei Tan; David G Allen; Shannon Bell; Paul C Brown; Lauren Browning; Patricia Ceger; Jeffery Gearhart; Pertti J Hakkinen; Shruti V Kabadi; Nicole C Kleinstreuer; Annie Lumen; Joanna Matheson; Alicia Paini; Heather A Pangburn; Elijah J Petersen; Emily N Reinke; Alexandre J S Ribeiro; Nisha Sipes; Lisa M Sweeney; John F Wambaugh; Ronald Wange; Barbara A Wetmore; Moiz Mumtaz
Journal:  Toxics       Date:  2022-05-01

4.  Assessment of RNA extraction protocols from cladocerans.

Authors:  Muhammad Raznisyafiq Razak; Ahmad Zaharin Aris; Fatimah Md Yusoff; Zetty Norhana Balia Yusof; Sang Don Kim; Kyoung Woong Kim
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

Review 5.  Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation.

Authors:  Rajkumar Cheluvappa; Paul Scowen; Rajaraman Eri
Journal:  Pharmacol Res Perspect       Date:  2017-08

6.  Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection.

Authors:  D Gholobova; M Gerard; L Decroix; L Desender; N Callewaert; P Annaert; L Thorrez
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

7.  Proteomic analysis of chicken bone marrow-derived dendritic cells in response to an inactivated IBV + NDV poultry vaccine.

Authors:  Robin H G A van den Biggelaar; Larissa van der Maas; Hugo D Meiring; Jeroen L A Pennings; Willem van Eden; Victor P M G Rutten; Christine A Jansen
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

8.  MAPK and Notch-Mediated Effects of Meso-Xanthin F199 Compounds on Proliferative Activity and Apoptosis of Human Melanocytes in Three-Dimensional Culture.

Authors:  Irina N Saburina; Irina M Zurina; Nastasia V Kosheleva; Anastasiya A Gorkun; Elena N Volkova; Olga S Grinakovskaya; Anton S Rybakov; Anna L Kaysheva; Arthur T Kopylov; Sergey G Morozov
Journal:  Biomed Res Int       Date:  2021-07-20       Impact factor: 3.411

9.  27Al NMR Study of the pH Dependent Hydrolysis Products of Al₂(SO₄)₃ in Different Physiological Media.

Authors:  Svend Berger; Jürgen Nolde; Timucin Yüksel; Wolfgang Tremel; Mihail Mondeshki
Journal:  Molecules       Date:  2018-04-02       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.